Masimo (NASDAQ:MASI) Hits New 1-Year Low – Time to Sell?

Masimo Corporation (NASDAQ:MASI)’s share price hit a new 52-week low on Monday . The stock traded as low as $131.43 and last traded at $131.3680, with a volume of 69156 shares traded. The stock had previously closed at $132.76.

Analyst Upgrades and Downgrades

MASI has been the topic of a number of recent research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Monday, December 1st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. Zacks Research cut Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. Bank of America started coverage on Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective for the company. Finally, Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $189.40.

Masimo Price Performance

The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. The stock’s 50-day moving average is $142.56 and its two-hundred day moving average is $149.27. The company has a market capitalization of $7.05 billion, a PE ratio of -12.46, a price-to-earnings-growth ratio of 1.44 and a beta of 1.26.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The company had revenue of $617.00 million for the quarter. On average, equities analysts predict that Masimo Corporation will post 4.1 EPS for the current year.

Institutional Trading of Masimo

A number of institutional investors have recently made changes to their positions in MASI. Twin Tree Management LP purchased a new stake in shares of Masimo in the first quarter worth about $29,000. MAI Capital Management lifted its holdings in Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares in the last quarter. Hilltop National Bank acquired a new position in Masimo during the second quarter worth about $37,000. Smartleaf Asset Management LLC boosted its holdings in shares of Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 136 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new stake in shares of Masimo in the 3rd quarter worth $46,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.